Join to View Full Profile
185 Cambridge stBoston, MA 02114
Dr. Spanos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I specialize in liquid biopsy for cardiovascular diseases, with a focus on developing novel biomarkers for the diagnosis and prognosis of these conditions. Additionally, I lead the SEAL-HF study, which investigates RNA profiles in extracellular vesicles to develop new diagnostic tests for heart failure, aiming to enhance early detection and improve patient outcomes.
My research centers on the application of Extracellular Vesicles (EVs) and extracellular RNAs (exRNAs) as non-invasive diagnostic and therapeutic tools. I am dedicated to advancing methods for capturing and analyzing cardiomyocyte-specific EVs from various biofluids, including blood and saliva.
Education & Training
Athens Medical School, National & Kapodistrian University of AthensClass of 2020
Clinical Trials
- Salivary Extracellular Vesicle Associated lncRNAs in Heart Failure (SEAL-HF) Start of enrollment: 2023 Apr 19
Roles: Contact, Study Director
Publications & Presentations
PubMed
- Nanomedicines for cardiovascular diseases: Lessons learned and pathways forward.Yi-An Mao, Xiaozhou Shi, Pingyuan Sun, Michail Spanos, Liyun Zhu
Biomaterials. 2025-09-01 - Cascade Nanozyme Delivering miRNA to Ischemic Heart to Alleviate Myocardial Ischemia-Reperfusion Injury.Xuerui Chen, Hang Chen, Liyun Zhu, Qian Li, Pingyuan Sun
Small. 2025-04-28 - Injectable hydrogel with miR-222-engineered extracellular vesicles ameliorates myocardial ischemic reperfusion injury via mechanotransduction.Yongtao Wang, Danni Meng, Xiaohui Shi, Yan Hou, Shihui Zang
Cell Reports. Medicine. 2025-03-18
Press Mentions
Molecules produced by cells in response to stress may be indicators of various diseasesApril 4th, 2022
Committees
- Editorial Board, Journal of Cardiovascular Translational Research 2022 - Present
Other Languages
- Greek
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
